RNC Capital Management LLC trimmed its position in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 8.4% during the fourth quarter, HoldingsChannel reports. The firm owned 16,337 shares of the healthcare conglomerate’s stock after selling 1,491 shares during the quarter. RNC Capital Management LLC’s holdings in UnitedHealth Group were worth $8,264,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors also recently made changes to their positions in UNH. Kathleen S. Wright Associates Inc. bought a new stake in UnitedHealth Group in the 3rd quarter valued at $27,000. West Financial Advisors LLC bought a new stake in UnitedHealth Group in the 3rd quarter valued at $32,000. AlphaMark Advisors LLC bought a new stake in UnitedHealth Group in the 4th quarter valued at $30,000. RPg Family Wealth Advisory LLC bought a new stake in UnitedHealth Group in the 3rd quarter valued at $37,000. Finally, Friedenthal Financial bought a new stake in UnitedHealth Group in the 3rd quarter valued at $51,000. 87.86% of the stock is owned by institutional investors.
Analyst Ratings Changes
Several brokerages have issued reports on UNH. Morgan Stanley lowered their price target on shares of UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating on the stock in a research note on Wednesday, October 16th. Deutsche Bank Aktiengesellschaft lifted their price target on shares of UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a research note on Tuesday, December 3rd. Wells Fargo & Company lowered their price objective on shares of UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 28th. TD Cowen boosted their price objective on shares of UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a research note on Friday, October 18th. Finally, Truist Financial lowered their price objective on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. One equities research analyst has rated the stock with a hold rating, twenty have given a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat.com, UnitedHealth Group presently has a consensus rating of “Buy” and an average price target of $629.32.
Insider Buying and Selling at UnitedHealth Group
In related news, Director Timothy Patrick Flynn bought 1,000 shares of the business’s stock in a transaction on Friday, January 17th. The shares were purchased at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the transaction, the director now directly owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. This represents a 28.57 % increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available through this link. Company insiders own 0.33% of the company’s stock.
UnitedHealth Group Stock Performance
Shares of UnitedHealth Group stock opened at $529.71 on Friday. The company has a 50 day moving average of $532.43 and a 200-day moving average of $564.77. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $630.73. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The company has a market cap of $487.48 billion, a PE ratio of 34.17, a price-to-earnings-growth ratio of 1.48 and a beta of 0.61.
UnitedHealth Group (NYSE:UNH – Get Free Report) last issued its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. During the same quarter in the prior year, the firm posted $5.83 EPS. The firm’s quarterly revenue was up 6.8% on a year-over-year basis. As a group, equities research analysts forecast that UnitedHealth Group Incorporated will post 29.63 earnings per share for the current fiscal year.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Read More
- Five stocks we like better than UnitedHealth Group
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Price Plunge in Roblox Presents Opportunity for Robust Gains
- 3 Monster Growth Stocks to Buy Now
- Billions in Buybacks: 4 Stocks Rewarding Shareholders Now
- Options Trading – Understanding Strike Price
- 3 Steel Stocks to Gain Strength as Tariffs Reshape the Market
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.